Introduction

Teething represents a developmentally normal process affecting infants from approximately 6-24 months of age as primary teeth erupt through alveolar bone and mucosal tissues. Despite the universal nature of tooth eruption, extensive mythology has developed regarding associated symptoms and effective interventions, perpetuating unproven remedies and potentially harmful practices. Comprehensive understanding of evidence-based teething symptoms and interventions enables practitioners to counsel parents effectively and redirect from unsafe folk remedies toward proven approaches.

Teething Timeline and Developmental Patterns

Primary tooth eruption typically initiates between 4-7 months of age, with most children demonstrating first tooth emergence between 6-9 months. Eruption sequence shows considerable individual variation, though mandibular central incisors commonly erupt first (approximately 6-10 months of age), followed by maxillary central incisors (8-13 months).

Eruption proceeds over subsequent months, with all 20 primary teeth typically erupted by 24-36 months of age (range: 12-42 months, representing wide normal variation). Eruption rate and sequence demonstrate genetic influence, with parental eruption timing frequently predicting offspring patterns within normal variation ranges.

Systemic symptoms attributable directly to tooth eruption remain limited and controversial. Longitudinal prospective cohort studies (most rigorous evidence available) document that teething reliably produces localized gingival inflammation, erythema, and drooling, while systemic symptoms demonstrate lower causal association.

Teething Symptoms: Proven versus Unproven

Proven teething symptoms (well-documented in prospective studies):
  • Localized gingival swelling and inflammation at eruption sites
  • Erythema (redness) at eruption location
  • Drooling (increased salivary production)
  • Desire to bite/chew objects and fingers
  • Localized gingival pain/tenderness at eruption site
  • Restlessness and irritability (presumably related to localized discomfort)
Potentially related but inconsistently documented:
  • Fever: Multiple prospective studies demonstrate unclear association, with low-grade fever (<38.3°C) possibly related to teething inflammation in some cases. High fever (>38.3°C) remains atypical for teething and warrants investigation for alternative etiologies (infection, systemic illness).
  • Diarrhea: Prospective cohort studies show conflicting evidence, with some studies documenting increased diarrhea incidence during teething intervals, others showing no association. Etiology unclear (possibly increased saliva swallowing, teething biscuit ingestion, or concurrent gastrointestinal infection).
  • Disrupted sleep: Irritability and discomfort may alter sleep patterns, though prospective studies show highly variable individual effects.
  • Ear pulling/rubbing: Observed frequently during teething but remains poorly explained and may reflect non-specific discomfort manifestation.
NOT reliably associated with teething (unproven in prospective studies):
  • Infections (otitis media, upper respiratory tract infections)
  • High fever (>38.3°C)
  • Vomiting or significant gastrointestinal symptoms
  • Rash (beyond possible inflammation-induced erythema at eruption site)
  • Cough or respiratory symptoms
  • Swollen lymph nodes
Parents frequently attribute concurrent illnesses to teething coincidentally, as winter upper respiratory infections and otitis media occur within same age range as peak teething activity (6-24 months). Temporal association creates mistaken causal attribution.

Fever and Teething: Separating Association from Causation

Fever represents the most commonly cited systemic symptom attributed to teething, though evidence remains inconsistent. Prospective cohort studies examining fever in relation to tooth eruption document:

  • Fever (any elevation above 37°C/98.6°F) occurs in 5-10% of teething episodes
  • Low-grade fever (<38.3°C/101°F) possibly related to teething inflammation in <5% of cases
  • High fever (>38.3°C/101°F) shows no reliable association with tooth eruption, warranting investigation for alternative causes (infection, systemic illness)
Published guidelines from major organizations (American Academy of Pediatrics, American Academy of Pediatric Dentistry) explicitly state that high fever (temperature >38.3°C) is not a normal teething symptom and indicates need for medical evaluation to exclude infection or other systemic disease.

The proposed mechanism for low-grade fever involves local gingival inflammation stimulating minor systemic inflammatory response (interleukin release, slight temperature elevation), though this remains speculative and inconsistently documented.

Amber Teething Necklaces: Lack of Evidence and Safety Concerns

Amber teething necklaces represent a popular folk remedy based on claims that amber releases succinic acid (and other compounds) through skin contact, producing pain relief and anti-inflammatory effects. Scientific evidence does not support therapeutic efficacy, and safety concerns create potential hazards.

Efficacy evidence:
  • No published clinical trials demonstrate succinic acid absorption through intact skin at concentrations sufficient for therapeutic effect
  • No randomized controlled trials document pain relief or symptom improvement with amber necklace use
  • Published chemical analysis demonstrates variability in amber composition, with uncertain succinic acid content and no reliable bioavailability through dermal contact
Safety concerns:
  • Strangulation risk: Breakaway necklace designs remain imperfectly reliable, with documented case reports of strangling injuries
  • Aspiration risk: Broken necklace fragments may be aspirated, creating airway emergency
  • Choking risk: Loose beads create aspiration/choking hazard
  • Chemical burns: Some necklace designs demonstrate heating (claimed to release succinic acid), with potential thermal injury risk
  • Contact dermatitis: Amber contact may produce dermatitis in sensitive infants
American Academy of Pediatric Dentistry and American Academy of Pediatrics explicitly recommend against amber necklace use due to safety concerns outweighing unproven benefit.

Benzocaine Products and FDA Safety Warnings

Benzocaine topical anesthetic products (viscous gels, sprays) historically recommended for teething have been withdrawn from pediatric use following FDA safety alerts documenting methemoglobinemia risk.

Mechanism of harm:

Benzocaine (and other local anesthetics including prilocaine, lidocaine at high concentrations) can oxidize hemoglobin to methemoglobin, creating oxygen-carrying capacity loss. In infants <6 months and those with underlying hemoglobinopathy (sickle cell, glucose-6-phosphate dehydrogenase deficiency), even modest methemoglobin levels produce clinical cyanosis and hypoxemia.

Clinical manifestations of methemoglobinemia:
  • Cyanosis (blue/gray skin discoloration) unresponsive to supplemental oxygen
  • Dyspnea and respiratory difficulty
  • Lethargy and reduced consciousness
  • Seizures in severe cases
FDA actions and recommendations:

The FDA issued Drug Safety Communications in 2011-2014 recommending against benzocaine use in teething (particularly children <2 years), citing methemoglobinemia risk. While full product withdrawals have not occurred, major manufacturers voluntarily discontinued pediatric teething product lines.

Products containing benzocaine should be explicitly avoided for teething management. Parents using legacy benzocaine products (remaining in some household medicine cabinets) should be counseled to discontinue and safely discard these products.

Homeopathic Teething Products: Lack of Evidence and Safety Concerns

Homeopathic teething tablets and liquids (including popular brands like Hyland's Teething Tablets) have gained parental popularity despite lack of clinical evidence and documented safety concerns.

Efficacy evidence:
  • No randomized controlled trials demonstrate efficacy superior to placebo
  • Homeopathic principles (extreme dilution producing biological activity) lack mechanistic plausibility and contradict pharmacologic principles
  • Published meta-analyses of homeopathic interventions for various indications conclude that effects beyond placebo remain unproven
Safety concerns:
  • Contamination risks: FDA testing identified bacterial contamination in some products
  • Choking hazard: Tablet formulations present aspiration risk in young children
  • Nightshade alkaloid content: Some products contain belladonna derivatives (atropine precursors), which at significant doses produce anticholinergic effects (tachycardia, mydriasis, hyperthermia, altered consciousness)
  • Neuropathy reports: Sporadic case reports document developmental delays and neuropathic symptoms following prolonged use, mechanism unclear
FDA issued warning letters to manufacturers regarding contamination and safety concerns. While products remain commercially available, they are not recommended by evidence-based pediatric organizations.

Safe and Effective Teething Interventions

Physical interventions (proven safe and effective):
  • Cold teething rings or objects: Refrigerated (not frozen) rubber teething rings provide topical anesthetic effect through cold-induced local anesthesia and mild inflammation reduction. Most effective when kept at refrigerated temperatures (4-10°C), as frozen objects may cause local tissue damage.
  • Gingival massage: Gentle finger massage applied to eruption site (with clean, wet finger) provides mechanical relief through pressure application and mild inflammation reduction. Parents often report infants finding this particularly soothing.
  • Increased drooling management: White cotton cloth or bib worn to maintain dryness and prevent drooling-related skin irritation (drooling creates acidic environment promoting dermatitis). Frequent changes and careful drying reduce secondary skin inflammation.
  • Distraction and comforting: Increased parental comfort, holding, and age-appropriate distraction activities provide non-pharmacologic symptom management through behavioral approaches.
Topical medication use (limited evidence but considered safer than systemic approaches):
  • Topical fluoride: While not specifically targeting teething pain, topical fluoride application provides protective effect against early childhood caries commonly emerging during primary tooth eruption period (12-24 months). Daily 1.1% sodium fluoride rinse (or 0.4% stannous fluoride gel) provides demineralization protection.
  • Topical anesthetics (non-benzocaine): While systematic evidence remains limited, low-concentration topical anesthetics lacking methemoglobinemia risk may provide temporary localized relief. Practitioners should recommend only products with documented safety profiles in pediatric populations.
Systemic medications (reserved for significant discomfort):
  • Acetaminophen or ibuprofen: Limited systemic administration for significant teething discomfort remains appropriate, following weight-based dosing guidelines and appropriate intervals. Should not be administered prophylactically but reserved for documented discomfort.
What to AVOID:
  • Teething biscuits or hard food objects: Risk of aspiration, choking, and tooth damage
  • Topical benzocaine or prilocaine products (methemoglobinemia risk)
  • Amber necklaces (strangulation, choking, aspiration risk)
  • Homeopathic teething products (unproven efficacy, contamination risk)
  • Teething medication with belladonna alkaloids (toxicity risk)
  • Frozen teething rings or ice (tissue damage risk)

Parent Counseling and Education

Effective counseling addresses parental expectations and redirects from folk remedies toward evidence-based interventions:

Normalize teething discomfort: Reassure parents that localized gingival discomfort is normal and self-limited, resolving within 24-48 hours following tooth eruption. Significant disability or high fever warrants evaluation to exclude alternative causes. Explain symptom attribution bias: Parents naturally attribute coincident illnesses to teething coincidentally. High fever, respiratory symptoms, infections, or prolonged diarrhea warrant medical evaluation rather than attribution to teething alone. Provide concrete safe interventions: Specific counseling regarding cold teething rings, gingival massage, and distraction activities gives parents evidence-based options reducing reliance on ineffective or harmful folk remedies. Identify unsafe products: Explicit warning against amber necklaces, benzocaine products, and homeopathic tablets clarifies why parents should avoid these despite widespread availability and marketing claims. Reinforce infection prevention: Counseling regarding hand hygiene, avoiding shared utensils, and preventing exposure to sick contacts remains important during teething interval when infants explore environment via mouth.

Conclusion

Teething represents a normal developmental process producing localized gingival inflammation, discomfort, and behavioral changes, but systemic symptoms remain less reliably associated with tooth eruption. Fever >38.3°C, respiratory symptoms, infections, and gastrointestinal illness warrant medical evaluation rather than attribution to teething. Amber necklaces lack efficacy evidence and present significant safety hazards (strangulation, aspiration risk). Benzocaine teething products should be explicitly avoided due to documented methemoglobinemia risk. Homeopathic teething tablets lack efficacy evidence and demonstrate contamination and toxicity concerns. Safe effective interventions include cold (refrigerated, not frozen) teething rings, gingival massage, increased comfort/holding, and, when necessary, weight-appropriate acetaminophen or ibuprofen for significant discomfort. Parent education addressing symptom attribution bias and redirecting from folk remedies toward evidence-based interventions represents critical practitioner responsibility in pediatric populations.